# PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment

> **NCT01581541** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 17 (actual)

## Conditions studied

- Solid Tumors
- Lymphoma

## Interventions

- **DRUG:** PU-H71

## Key facts

- **NCT ID:** NCT01581541
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04-26
- **Primary completion:** 2014-09-03
- **Final completion:** 2014-09-03
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** The study closed prematurely due to discontinuation of drug supply.
- **Last updated:** 2017-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01581541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01581541, "PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01581541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*